» Articles » PMID: 35076578

Successful Treatment with Corticosteroids in an 11-Year-Old Patient with Crohn's Disease and Myopericarditis-Case Report

Overview
Journal Pediatr Rep
Publisher MDPI
Specialty Pediatrics
Date 2022 Jan 25
PMID 35076578
Authors
Affiliations
Soon will be listed here.
Abstract

Extraintestinal manifestations (EIMs) are observed in 15-20% of patients with inflammatory bowel disease (IBD). One of the rare EIMs is myocarditis, the incidence of which is estimated at around 1%. The main cause of myocarditis is a viral infection. Other causes include autoimmune diseases and drug complications (sulfasalazine, mesalazine). We present the case of an 11-year-old girl with Crohn's disease (CD) with EIMs, manifested as hip joint inflammation and erythema nodosum. At the same time, the symptoms of myopericarditis appeared with changes in electrocardiogram (ECG), echocardiography and high troponin I concentration. Therapy with corticosteroids resulted in the resolution of skin lesions and cardiological symptoms. Systemic connective tissue diseases, viral and bacterial infections were excluded in the differential diagnosis. The suspicion of mesalazine-induced EIMs was also ruled out as the symptoms resolved despite continued therapy with mesalazine. No further recurrences of myopericarditis were observed.

Citing Articles

Pancreatic Involvement in the Course of Inflammatory Bowel Disease in Children-A Multi-Center Study.

Daniluk U, Krawiec P, Pac-Kozuchowska E, Dembinski L, Bukowski J, Banaszkiewicz A J Clin Med. 2023; 12(13).

PMID: 37445210 PMC: 10342734. DOI: 10.3390/jcm12134174.


Diagnosis of Concomitant Myocarditis in a 13-Year-Old Patient with Crohn's Disease.

Kim J, Kim S, Kim Y Children (Basel). 2022; 9(11).

PMID: 36360391 PMC: 9688279. DOI: 10.3390/children9111663.


A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.

Cesa K, Cunningham C, Harris T, Sunseri W Cureus. 2022; 14(6):e26366.

PMID: 35911289 PMC: 9334219. DOI: 10.7759/cureus.26366.

References
1.
Gujral N, Friedenberg F, Friedenberg J, Gabriel G, Kotler M, Levine G . Pleuropericarditis related to the use of mesalamine. Dig Dis Sci. 1996; 41(3):624-6. DOI: 10.1007/BF02282352. View

2.
Cooper L, Baughman K, Feldman A, Frustaci A, Jessup M, Kuhl U . The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure.... Eur Heart J. 2007; 28(24):3076-93. DOI: 10.1093/eurheartj/ehm456. View

3.
Oh I, Choi C, Park J, Kim J, Cha B, Do J . A case of acute myocarditis as the initial presentation of Crohn's disease. Gut Liver. 2012; 6(4):512-5. PMC: 3493735. DOI: 10.5009/gnl.2012.6.4.512. View

4.
Lezcano-Gort L, Gomez-Barrado J, Mogollon-Jimenez M, Garciperez-de-Vargas-Diaz F . Hypersensitivity perimyocarditis after the first dose of infliximab. Rev Esp Enferm Dig. 2015; 107(4):249. View

5.
Magnani J, Dec G . Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113(6):876-90. DOI: 10.1161/CIRCULATIONAHA.105.584532. View